nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Corneal thinning—Betamethasone—psoriatic arthritis	0.031	0.0311	CcSEcCtD
Phenylephrine—Posterior subcapsular cataract—Dexamethasone—psoriatic arthritis	0.0271	0.0272	CcSEcCtD
Phenylephrine—Posterior subcapsular cataract—Betamethasone—psoriatic arthritis	0.0271	0.0272	CcSEcCtD
Phenylephrine—Nerve injury—Prednisolone—psoriatic arthritis	0.023	0.0231	CcSEcCtD
Phenylephrine—Corneal oedema—Betamethasone—psoriatic arthritis	0.02	0.0201	CcSEcCtD
Phenylephrine—Corneal oedema—Dexamethasone—psoriatic arthritis	0.02	0.0201	CcSEcCtD
Phenylephrine—Cataract subcapsular—Prednisolone—psoriatic arthritis	0.0193	0.0193	CcSEcCtD
Phenylephrine—Nerve injury—Betamethasone—psoriatic arthritis	0.0192	0.0193	CcSEcCtD
Phenylephrine—Nerve injury—Dexamethasone—psoriatic arthritis	0.0192	0.0193	CcSEcCtD
Phenylephrine—Vitreous floaters—Dexamethasone—psoriatic arthritis	0.0185	0.0185	CcSEcCtD
Phenylephrine—Vitreous floaters—Betamethasone—psoriatic arthritis	0.0185	0.0185	CcSEcCtD
Phenylephrine—Cataract subcapsular—Triamcinolone—psoriatic arthritis	0.0177	0.0178	CcSEcCtD
Phenylephrine—Cataract subcapsular—Methylprednisolone—psoriatic arthritis	0.0177	0.0177	CcSEcCtD
Phenylephrine—Nerve injury—Prednisone—psoriatic arthritis	0.0167	0.0168	CcSEcCtD
Phenylephrine—Eye infection—Prednisolone—psoriatic arthritis	0.0162	0.0163	CcSEcCtD
Phenylephrine—Cataract subcapsular—Dexamethasone—psoriatic arthritis	0.0161	0.0161	CcSEcCtD
Phenylephrine—Cataract subcapsular—Betamethasone—psoriatic arthritis	0.0161	0.0161	CcSEcCtD
Phenylephrine—Cataract subcapsular—Prednisone—psoriatic arthritis	0.014	0.014	CcSEcCtD
Phenylephrine—Hyperaemia—Dexamethasone—psoriatic arthritis	0.0139	0.0139	CcSEcCtD
Phenylephrine—Hyperaemia—Betamethasone—psoriatic arthritis	0.0139	0.0139	CcSEcCtD
Phenylephrine—Eye infection—Betamethasone—psoriatic arthritis	0.0135	0.0136	CcSEcCtD
Phenylephrine—Eye infection—Dexamethasone—psoriatic arthritis	0.0135	0.0136	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Prednisolone—psoriatic arthritis	0.0114	0.0115	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Triamcinolone—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Methylprednisolone—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Dexamethasone—psoriatic arthritis	0.00954	0.00957	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Betamethasone—psoriatic arthritis	0.00954	0.00957	CcSEcCtD
Phenylephrine—Skin necrosis—Methotrexate—psoriatic arthritis	0.00874	0.00877	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Prednisone—psoriatic arthritis	0.00831	0.00833	CcSEcCtD
Phenylephrine—Keratitis—Prednisolone—psoriatic arthritis	0.00775	0.00778	CcSEcCtD
Phenylephrine—Visual impairment—Auranofin—psoriatic arthritis	0.00763	0.00765	CcSEcCtD
Phenylephrine—Rales—Methotrexate—psoriatic arthritis	0.00744	0.00747	CcSEcCtD
Phenylephrine—Dysgeusia—Auranofin—psoriatic arthritis	0.00675	0.00677	CcSEcCtD
Phenylephrine—Keratitis—Betamethasone—psoriatic arthritis	0.00647	0.00649	CcSEcCtD
Phenylephrine—Keratitis—Dexamethasone—psoriatic arthritis	0.00647	0.00649	CcSEcCtD
Phenylephrine—Mydriasis—Prednisolone—psoriatic arthritis	0.00631	0.00632	CcSEcCtD
Phenylephrine—Stinging—Prednisolone—psoriatic arthritis	0.00621	0.00622	CcSEcCtD
Phenylephrine—Eye irritation—Prednisolone—psoriatic arthritis	0.00589	0.00591	CcSEcCtD
Phenylephrine—Stinging—Triamcinolone—psoriatic arthritis	0.00571	0.00572	CcSEcCtD
Phenylephrine—Stinging—Dexamethasone—psoriatic arthritis	0.00518	0.00519	CcSEcCtD
Phenylephrine—Stinging—Betamethasone—psoriatic arthritis	0.00518	0.00519	CcSEcCtD
Phenylephrine—Extravasation—Dexamethasone—psoriatic arthritis	0.00481	0.00482	CcSEcCtD
Phenylephrine—Extravasation—Betamethasone—psoriatic arthritis	0.00481	0.00482	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.00448	0.00449	CcSEcCtD
Phenylephrine—Urticaria—Auranofin—psoriatic arthritis	0.00447	0.00448	CcSEcCtD
Phenylephrine—Skin exfoliation—Triamcinolone—psoriatic arthritis	0.00442	0.00443	CcSEcCtD
Phenylephrine—Skin exfoliation—Methylprednisolone—psoriatic arthritis	0.00441	0.00442	CcSEcCtD
Phenylephrine—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.00412	0.00413	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.00411	0.00412	CcSEcCtD
Phenylephrine—Skin exfoliation—Dexamethasone—psoriatic arthritis	0.00401	0.00402	CcSEcCtD
Phenylephrine—Skin exfoliation—Betamethasone—psoriatic arthritis	0.00401	0.00402	CcSEcCtD
Phenylephrine—Pruritus—Auranofin—psoriatic arthritis	0.00398	0.00399	CcSEcCtD
Phenylephrine—Visual disturbance—Prednisolone—psoriatic arthritis	0.00385	0.00386	CcSEcCtD
Phenylephrine—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.00374	0.00375	CcSEcCtD
Phenylephrine—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.00374	0.00375	CcSEcCtD
Phenylephrine—Vomiting—Auranofin—psoriatic arthritis	0.00358	0.00359	CcSEcCtD
Phenylephrine—Rash—Auranofin—psoriatic arthritis	0.00355	0.00356	CcSEcCtD
Phenylephrine—Dermatitis—Auranofin—psoriatic arthritis	0.00354	0.00355	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—psoriatic arthritis	0.0035	0.00351	CcSEcCtD
Phenylephrine—Skin exfoliation—Prednisone—psoriatic arthritis	0.00349	0.0035	CcSEcCtD
Phenylephrine—Eye pain—Dexamethasone—psoriatic arthritis	0.00337	0.00338	CcSEcCtD
Phenylephrine—Eye pain—Betamethasone—psoriatic arthritis	0.00337	0.00338	CcSEcCtD
Phenylephrine—Nausea—Auranofin—psoriatic arthritis	0.00334	0.00335	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisone—psoriatic arthritis	0.00325	0.00326	CcSEcCtD
Phenylephrine—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00321	0.00322	CcSEcCtD
Phenylephrine—Visual disturbance—Betamethasone—psoriatic arthritis	0.00321	0.00322	CcSEcCtD
Phenylephrine—Sweating increased—Prednisolone—psoriatic arthritis	0.00307	0.00308	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Phenylephrine—Sweating increased—Triamcinolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Phenylephrine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00282	0.00283	CcSEcCtD
Phenylephrine—Epinephrine—TNF—psoriatic arthritis	0.0028	1	CrCbGaD
Phenylephrine—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00277	0.00278	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00276	0.00277	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00272	0.00273	CcSEcCtD
Phenylephrine—Bradycardia—Prednisolone—psoriatic arthritis	0.00257	0.00258	CcSEcCtD
Phenylephrine—Sweating increased—Dexamethasone—psoriatic arthritis	0.00256	0.00257	CcSEcCtD
Phenylephrine—Sweating increased—Betamethasone—psoriatic arthritis	0.00256	0.00257	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00255	0.00256	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00254	0.00255	CcSEcCtD
Phenylephrine—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Phenylephrine—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00253	0.00254	CcSEcCtD
Phenylephrine—Visual impairment—Prednisolone—psoriatic arthritis	0.00243	0.00244	CcSEcCtD
Phenylephrine—Bradycardia—Triamcinolone—psoriatic arthritis	0.00236	0.00237	CcSEcCtD
Phenylephrine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00236	0.00237	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—psoriatic arthritis	0.00234	0.00235	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00231	0.00232	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00231	0.00232	CcSEcCtD
Phenylephrine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.0023	0.00231	CcSEcCtD
Phenylephrine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.0023	0.00231	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Phenylephrine—Sweating increased—Prednisone—psoriatic arthritis	0.00223	0.00224	CcSEcCtD
Phenylephrine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00223	0.00224	CcSEcCtD
Phenylephrine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00215	0.00216	CcSEcCtD
Phenylephrine—Bradycardia—Dexamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Phenylephrine—Bradycardia—Betamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Phenylephrine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.0021	0.00211	CcSEcCtD
Phenylephrine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00209	0.0021	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Phenylephrine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00207	0.00208	CcSEcCtD
Phenylephrine—Vision blurred—Prednisolone—psoriatic arthritis	0.00207	0.00208	CcSEcCtD
Phenylephrine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00207	0.00208	CcSEcCtD
Phenylephrine—Visual impairment—Betamethasone—psoriatic arthritis	0.00203	0.00204	CcSEcCtD
Phenylephrine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00203	0.00204	CcSEcCtD
Phenylephrine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00203	0.00204	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisone—psoriatic arthritis	0.002	0.00201	CcSEcCtD
Phenylephrine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00198	0.00199	CcSEcCtD
Phenylephrine—Syncope—Prednisolone—psoriatic arthritis	0.00197	0.00198	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00193	0.00194	CcSEcCtD
Phenylephrine—Angiopathy—Betamethasone—psoriatic arthritis	0.00191	0.00192	CcSEcCtD
Phenylephrine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00191	0.00192	CcSEcCtD
Phenylephrine—Hypertension—Prednisolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Phenylephrine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00188	0.00189	CcSEcCtD
Phenylephrine—Arrhythmia—Betamethasone—psoriatic arthritis	0.00188	0.00189	CcSEcCtD
Phenylephrine—Bradycardia—Prednisone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Phenylephrine—Syncope—Triamcinolone—psoriatic arthritis	0.00181	0.00182	CcSEcCtD
Phenylephrine—Syncope—Methylprednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Phenylephrine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Phenylephrine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00177	0.00178	CcSEcCtD
Phenylephrine—Shock—Prednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Phenylephrine—Tachycardia—Prednisolone—psoriatic arthritis	0.00175	0.00176	CcSEcCtD
Phenylephrine—Hypertension—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Phenylephrine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00174	0.00175	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00173	0.00174	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Phenylephrine—Angiopathy—Prednisone—psoriatic arthritis	0.00166	0.00167	CcSEcCtD
Phenylephrine—Immune system disorder—Prednisone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Phenylephrine—Syncope—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Phenylephrine—Syncope—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Phenylephrine—Shock—Triamcinolone—psoriatic arthritis	0.00162	0.00163	CcSEcCtD
Phenylephrine—Shock—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Phenylephrine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Phenylephrine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Phenylephrine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Phenylephrine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Phenylephrine—Mental disorder—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Phenylephrine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Phenylephrine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Phenylephrine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00159	0.0016	CcSEcCtD
Phenylephrine—Hypertension—Dexamethasone—psoriatic arthritis	0.00158	0.00159	CcSEcCtD
Phenylephrine—Hypertension—Betamethasone—psoriatic arthritis	0.00158	0.00159	CcSEcCtD
Phenylephrine—Pain—Prednisolone—psoriatic arthritis	0.00153	0.00154	CcSEcCtD
Phenylephrine—Vision blurred—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Phenylephrine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00148	0.00149	CcSEcCtD
Phenylephrine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Phenylephrine—Shock—Betamethasone—psoriatic arthritis	0.00147	0.00148	CcSEcCtD
Phenylephrine—Shock—Dexamethasone—psoriatic arthritis	0.00147	0.00148	CcSEcCtD
Phenylephrine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00147	0.00148	CcSEcCtD
Phenylephrine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Phenylephrine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Phenylephrine—Agitation—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Phenylephrine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00146	0.00147	CcSEcCtD
Phenylephrine—Tachycardia—Betamethasone—psoriatic arthritis	0.00146	0.00147	CcSEcCtD
Phenylephrine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Phenylephrine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Phenylephrine—Syncope—Prednisone—psoriatic arthritis	0.00143	0.00144	CcSEcCtD
Phenylephrine—Urticaria—Prednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00142	0.00143	CcSEcCtD
Phenylephrine—Pain—Triamcinolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisone—psoriatic arthritis	0.0014	0.00141	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—psoriatic arthritis	0.00139	0.0014	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00138	0.00139	CcSEcCtD
Phenylephrine—Hypertension—Prednisone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Phenylephrine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00134	0.00135	CcSEcCtD
Phenylephrine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00134	0.00135	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—psoriatic arthritis	0.00134	0.00135	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00132	0.00133	CcSEcCtD
Phenylephrine—Urticaria—Triamcinolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Phenylephrine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00129	0.0013	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00129	0.0013	CcSEcCtD
Phenylephrine—Shock—Prednisone—psoriatic arthritis	0.00128	0.00129	CcSEcCtD
Phenylephrine—Pain—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Phenylephrine—Pain—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Phenylephrine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Phenylephrine—Tachycardia—Prednisone—psoriatic arthritis	0.00127	0.00128	CcSEcCtD
Phenylephrine—Skin disorder—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Phenylephrine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Phenylephrine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00121	0.00122	CcSEcCtD
Phenylephrine—Urticaria—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Phenylephrine—Urticaria—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Phenylephrine—Dizziness—Prednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Phenylephrine—Pruritus—Triamcinolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Phenylephrine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00116	0.00117	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Phenylephrine—Rash—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Phenylephrine—Dermatitis—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Phenylephrine—Headache—Prednisolone—psoriatic arthritis	0.00112	0.00113	CcSEcCtD
Phenylephrine—Dizziness—Triamcinolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Phenylephrine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Phenylephrine—Nausea—Prednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Phenylephrine—Pruritus—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Phenylephrine—Pruritus—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00105	0.00106	CcSEcCtD
Phenylephrine—Vomiting—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Phenylephrine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Phenylephrine—Rash—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Phenylephrine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Phenylephrine—Rash—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Phenylephrine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Phenylephrine—Urticaria—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Phenylephrine—Headache—Triamcinolone—psoriatic arthritis	0.00103	0.00104	CcSEcCtD
Phenylephrine—Headache—Methylprednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Phenylephrine—Dizziness—Dexamethasone—psoriatic arthritis	0.00099	0.000993	CcSEcCtD
Phenylephrine—Dizziness—Betamethasone—psoriatic arthritis	0.00099	0.000993	CcSEcCtD
Phenylephrine—Nausea—Triamcinolone—psoriatic arthritis	0.00098	0.000983	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000978	0.000981	CcSEcCtD
Phenylephrine—Nausea—Methylprednisolone—psoriatic arthritis	0.000978	0.000981	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000971	0.000974	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000961	0.000963	CcSEcCtD
Phenylephrine—Vomiting—Dexamethasone—psoriatic arthritis	0.000952	0.000955	CcSEcCtD
Phenylephrine—Vomiting—Betamethasone—psoriatic arthritis	0.000952	0.000955	CcSEcCtD
Phenylephrine—Rash—Betamethasone—psoriatic arthritis	0.000944	0.000947	CcSEcCtD
Phenylephrine—Rash—Dexamethasone—psoriatic arthritis	0.000944	0.000947	CcSEcCtD
Phenylephrine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000943	0.000946	CcSEcCtD
Phenylephrine—Dermatitis—Betamethasone—psoriatic arthritis	0.000943	0.000946	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000941	0.000943	CcSEcCtD
Phenylephrine—Headache—Dexamethasone—psoriatic arthritis	0.000938	0.000941	CcSEcCtD
Phenylephrine—Headache—Betamethasone—psoriatic arthritis	0.000938	0.000941	CcSEcCtD
Phenylephrine—Pain—Methotrexate—psoriatic arthritis	0.000932	0.000934	CcSEcCtD
Phenylephrine—Pruritus—Prednisone—psoriatic arthritis	0.000922	0.000925	CcSEcCtD
Phenylephrine—Nausea—Betamethasone—psoriatic arthritis	0.000889	0.000892	CcSEcCtD
Phenylephrine—Nausea—Dexamethasone—psoriatic arthritis	0.000889	0.000892	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—psoriatic arthritis	0.000866	0.000868	CcSEcCtD
Phenylephrine—Dizziness—Prednisone—psoriatic arthritis	0.000862	0.000865	CcSEcCtD
Phenylephrine—Vomiting—Prednisone—psoriatic arthritis	0.000829	0.000831	CcSEcCtD
Phenylephrine—Rash—Prednisone—psoriatic arthritis	0.000822	0.000824	CcSEcCtD
Phenylephrine—Dermatitis—Prednisone—psoriatic arthritis	0.000821	0.000824	CcSEcCtD
Phenylephrine—Headache—Prednisone—psoriatic arthritis	0.000817	0.000819	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000803	0.000805	CcSEcCtD
Phenylephrine—Nausea—Prednisone—psoriatic arthritis	0.000774	0.000777	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—psoriatic arthritis	0.000771	0.000773	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—psoriatic arthritis	0.000721	0.000723	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—psoriatic arthritis	0.000693	0.000695	CcSEcCtD
Phenylephrine—Rash—Methotrexate—psoriatic arthritis	0.000687	0.000689	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—psoriatic arthritis	0.000686	0.000688	CcSEcCtD
Phenylephrine—Headache—Methotrexate—psoriatic arthritis	0.000683	0.000685	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—psoriatic arthritis	0.000647	0.000649	CcSEcCtD
